PATENT CLAIM ANALYSIS

Application Number: 16028469
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2020-01
Patent Classification: ["514", "052000"]

Abstract:
Disclosed is a Mecobalamin medicine given to a patient to relieve a patient's emergency drug addiction symptoms and pains before performing a subsequent poisoning pathway treatment to block a drug to achieve better treatment effect, when the patient is suffering a drug withdrawal.

Claim (Index 2):
The Mecobalamin for relieving emergency drug poisoning according to  claim 1 , wherein the poisoning pathway treatment prepares a drop prescription comprising a plurality of ingredients consisting of Cerebrolysin, Piracetam, Cimetidine, Scopolamine Butylbromide, Nefopam, B.C Complex, Vitamin B1, Ascorbic Acid, Ketorolac, Guronsan, Hyoscine Butylbromide, and Sukerin.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 95.0
- Lexical Diversity: 1.4375
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15000093', '11061715', '11072359', '12484567', '11096189']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.628585308956726
- 35 USC 102 Novelty (BERT): 0.4635361285590793
- Combined Prediction Score: 0.6120803909169613
- Mean Citation Score: 116.1511018
- Max Citation Score: 137.37105
- Similarity Product: 108.53717478643657

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test